• Decision-making CNS pharmacology from excitable cells and native tissue

    Cellectricon provides drug discovery services and state-of-the-art cellular screening technologies to accelerate drug discovery and cell-based assay research. Our proprietary platform solutions and services enable advances in CNS research.

  • Improving early-stage drug discovery

    Our Discovery Services provide academic, pharma, biotech and CRO organisations with cutting-edge phenotypic screening support, to help drug discovery teams shorten lead times and reduce costs.

Latest News

Scientific Resource Center

Scientific Resource Center

Take advantage of our scientific resource center featuring a vast library of application notes providing information and data generated on Cellectricon’s cell-based assay solutions.

View Document